Sylco, LLC

ATLANTA, United States

Sylco, LLC
Healthcare
Early stage
Development
£ 10,000
3%
Make an Offer

Summary

Sylco, LLC is a start-up Molecular Diagnostics Laboratory located in Atlanta, Georgia. We’re looking to spread services across the world by providing molecular biology techniques to study human disease, including infectious disease. Our team thrives on focusing on core molecular biology methods such as nucleic acid isolation and quantification, PCR amplification, analysis of STR, and sequencing.
We’re fully committed on working to spread help across the world to others addressing health issues and assisting government facilities with testing on specialized cases. We’re constructing an all hands on deck -team environment to achieve a large goal of spreading services across the world.
Every step of the way includes working on productive research and accurate findings. Some services that will be provided also are GI, Wound, Nail, Respiratory, Women’s Health and COVID-19.

The Business

Sylco, LLC is a start-up Molecular Diagnostics Laboratory located in Atlanta, Georgia. We’re looking to spread services across the world by providing molecular biology techniques to study human disease, including infectious disease. Our team thrives on focusing on core molecular biology methods such as nucleic acid isolation and quantification, PCR amplification, analysis of STR, and sequencing.
We’re fully committed on working to spread help across the world to others addressing health issues and assisting government facilities with testing on specialized cases. We’re constructing an all hands on deck -team environment to achieve a large goal of spreading services across the world.
Every step of the way includes working on productive research and accurate findings. Some services that will be provided also are GI, Wound, Nail, Respiratory, Women’s Health and COVID-19.

The Market

The global molecular diagnostics market size was valued at USD 36.2 billion in 2020 and is expected to expand at a compound annual growth rate of 3.9% to 2028. The growth can be attributed to technological advancements, rising elderly population and external funding for rising demand.

Objective/Future (Use of funds)

Use of funds will go towards building, resources, payroll, and equipment
Use of funds will go towards building, resources, payroll, and equipment

The Team

SYLVIA MOHAMMED - Chairman
A current Project Management Analyst with over 10 years of financial industry experience, with 3 years of Project Management experience. I'm currently working on a large scope program that consists of hired resources to perform research and accurate testing, spreading services across the world.

Growth Roadmap

Looking for the company to turn into a family business or merge with a large entity.

Uploaded Documents

No documents uploaded

£ 10,000
3%
Make an Offer